Skip to main content
Log in

A Study of the Metabolism of the New Nootropic Preparation Unifiram by Ultra-High Performance Liquid Chromatography–High-Resolution Mass Spectrometry

  • ARTICLES
  • Published:
Journal of Analytical Chemistry Aims and scope Submit manuscript

Abstract

The metabolism of the new nootropic drug unifiram is considered; this drug supposedly has significantly higher activity than that of piracetam, and it is under clinical trials as a means of improving memory and preventing Alzheimer’s disease, attention-deficit disorder, and various forms of dementia. The structures of two potential metabolites of unifiram are proposed. Based on the interpretation of the experimental mass spectra of precursor ions and product ions, the applicability of a non-target screening methodology with the use of ultra-high performance liquid chromatography–high-resolution mass spectrometry to the detection of these compounds was demonstrated. It was established that the supposed metabolites of unifiram can be determined only with the use of enzymatic hydrolysis, while mineral hydrolysis led to the complete destruction of both the unifiram itself and the hypothetical metabolites. The use of the proposed chromatographing and mass-spectrometric detection conditions makes it possible to detect unifiram metabolites within six days after a single administration of 10 mg of the substance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.

Similar content being viewed by others

REFERENCES

  1. Guandalini, L., Martino, M.V., Di Cesare Mannelli, L., Bartolucci, G., Melani, F., Malik, R., Dei, S., Floriddia, E., Manetti, D., Orlandi, F., Teodori, E., Ghelardini, C., and Romanelli, M.N., Bioorg. Med. Chem. Lett., 2015, vol. 25, no. 8, p. 1700.

    Article  CAS  Google Scholar 

  2. Martini, E., Norcini, M., Ghelardini, C., Manetti, D., Dei, S., Guandalini, L., Melchiorre, M., Pagella, S., Scapecchi, S., Teodori, E., and Romanelli, M.N., Bioorg. Med. Chem. Lett., 2008, vol. 16, no. 23, p. 10034.

    Article  CAS  Google Scholar 

  3. Martino, M.V., Guandalini, L., Di Cesare Mannelli, L., Menicatti, M., Bartolucci, G., Dei, S., Manetti, D., Teodori, E., Ghelardini, C., and Romanelli, M.N., Bioorg. Med. Chem. Lett., 2017, vol. 25, no. 6, p. 1795.

    Article  CAS  Google Scholar 

  4. Mondadori, C., Ducret, T., and Hausler, A., Psychopharmacology, 1992, vol. 108, nos. 1–2, p. 11.

    Article  CAS  Google Scholar 

  5. Galeotti, N., Ghelardini, C., Pittaluga, A., Pugliese, A.M., Bartolini, A., Manetti, D., Romanelli, M.N., and Gualtieri, F., Arch. Pharmacol., 2003, vol. 368, no. 6, p. 538.

    Article  CAS  Google Scholar 

  6. Mondadori, C., Life Sci., 1994, vol. 55, nos. 25–26, p. 2171.

    Article  CAS  Google Scholar 

  7. Malik, R., Gupta, R., Srivastava, S., and Choudhary, B.S., J. Biomol. Struct. Dyn., 2016, vol. 35, no. 11, p. 2382.

    Article  Google Scholar 

  8. Giurgea, C. and Salama, M., Prog. Neuro-Psychopharmacol., 1977, vol. 1, nos. 3–4, p. 235.

    Article  CAS  Google Scholar 

  9. Gouliaev, A.H. and Senning, A., Brain Res. Rev., 1994, vol. 19, no. 2, p. 180.

    Article  CAS  Google Scholar 

  10. Schindler, U., Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 1989, vol. 13, p. 99.

    Article  Google Scholar 

  11. Romanelli, M.N., Galeotti, N., Ghelardini, C., Manetti, D., Martini, E., and Gualtieri, F., CNS Drug Rev., 2006, vol. 12, no. 1, p. 39.

    Article  CAS  Google Scholar 

  12. Mondadori, C., Petschke, F., and Häusler, A., Pharmacopsychiatry, 1989, vol. 22, p. 102.

    Article  Google Scholar 

  13. Mondadori, C., Behav. Brain Res., 1993, vol. 59, nos. 1–2, p. 1.

    Article  CAS  Google Scholar 

  14. Malik, R., Sangwan, A., Saihgal, R., Jindal, D.P., and Piplani, P., Curr. Med. Chem., 2007, vol. 14, no. 2, p. 123.

    Article  CAS  Google Scholar 

  15. Gualtieri, F., J. Enzyme Inhib. Med. Chem., 2015, vol. 31, no. 2, p. 187.

    Article  Google Scholar 

  16. Dmitrieva, E.V., Temerdashev, A.Z., Azaryan, A.A., and Gashimova, E.M., Analitika Kontrol’, 2018, vol. 22, no. 1, p. 28.

    Google Scholar 

  17. Peters, F.T. and Meyer, M.R., Drug Test. Anal., 2011, vol. 3, nos. 7–8, p. 483.

    Article  CAS  Google Scholar 

  18. Wank, J., Wagner-Redeker, W., Taylor, A., Herbold, R., and Lassahn, P.-G., High-resolution, accurate mass measurements and metabolite identification: An automated approach using fragment prediction in combination with fragment ion search (FISh), Thermo Fisher Scientific Application, note 537, 2016.

  19. De Bruyn Kops, C., Stork, C., Sicho, M., Kochev, N., Svozil, D., Jeliazkova, N., and Kirchmair, J., Front. Chem., 2019, vol. 7, no. 402, p. 1.

    Article  Google Scholar 

Download references

Funding

This study was supported by the Ministry of Education and Science of the Russian Federation (project no. FZEN-2020-0022) and the Russian Foundation for Basic Research (project no. 19-43-230004 r_а) and carried out with the participation of specialists from the Environmental and Analytical Center of the Kuban State University (unique identifier RFMEFI59317Х0008).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Z. Temerdashev.

Additional information

Translated by V. Makhlyarchuk

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Temerdashev, A.Z., Zorina, M.O., Dmitrieva, E.V. et al. A Study of the Metabolism of the New Nootropic Preparation Unifiram by Ultra-High Performance Liquid Chromatography–High-Resolution Mass Spectrometry. J Anal Chem 76, 204–211 (2021). https://doi.org/10.1134/S1061934821020131

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1061934821020131

Keywords:

Navigation